Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study (Q46159445)
Jump to navigation
Jump to search
scientific article published on 9 December 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study |
scientific article published on 9 December 2008 |
Statements
1 reference
Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study (English)
1 reference
Mir Abolfazl Ostad
1 reference
Silke Eggeling
1 reference
Peter Tschentscher
1 reference
Edzard Schwedhelm
1 reference
Rainer Böger
1 reference
Philip Wenzel
1 reference
Thomas Meinertz
1 reference
Thomas Munzel
1 reference
Ascan Warnholtz
1 reference
9 December 2008
1 reference
1 reference
205
1 reference
1
1 reference
227-232
1 reference